Ropes & Gray advises TPG Capital on BVI’s acquisition of PhysIOL

Ropes & Gray has advised TPG Capital on the acquisition by BVI – one of its portfolio companies – of PhysIOL Group SA from TA Associates.  The transaction, which has been announced today, was backed by TPG Capital.  
 
BVI (Beaver-Visitec International) is a leading developer, manufacturer, and marketer of specialised surgical devices and custom procedure packs for the ophthalmic marketplace.  PhysIOL Group SA (PhysIOL) is a Belgium-based ophthalmic company specialising in the research, development, and manufacture of intraocular lenses (IOLs). 
 
The deal, which is expected to close in the first quarter of 2019, will allow BVI to expand its portfolio, furthering the company’s transformation into a fully-integrated, technology-enabled ophthalmic player.  
 
A cross-border and cross-practice Ropes & Gray team was led by private equity partner John Newton in London with finance partners Alexander Zeltser, in New York.  Other members of the team included tax partner Andrew Howard (London), executive compensation partner Allie Alperovich (New York), private equity associate Victoria McGrath (London) and finance associates Ana Biloglav (London) and Daniel Coyne (Boston).
 
Stibbe provided Belgian law advice on the deal.
 
Ropes & Gray has previously advised on two other add-on transactions for TPG Capital / BVI: Malosa Medical and Vitreq.  Additionally, Ropes & Gray also advised TPG Capital on its acquisition of BVI.